Dividend sustainability is highly questionable given that AFFO has frequently failed to cover payouts, with recurring capital expenditures often exceeding $5 million per quarter, further pressuring liquidity.
| Cash from Operations | 37.19M | 6.95M | -79.85M | 21.62M | 28.3M | 38.88M | 41.81M | 47.4M | 54.15M | 63.97M | 78.72M | 68.68M | -4.69M |
| Operating CF Growth % | 333.41% | 108.71% | -469.25% | -23.58% | -27.22% | -7% | -11.81% | -12.46% | -15.35% | -18.75% | 14.63% | 1565.33% | - |
| Operating CF / Revenue % | 10.87% | 2.03% | -22.57% | 6.25% | 8.42% | 11.8% | 10.96% | 12.64% | 14.94% | 20.57% | 26.03% | 27.77% | -8.02% |
| Net Income | -60.36M | -57.69M | -190.26M | -72.38M | -79.62M | -85.44M | -75.51M | -88.31M | -52.98M | -42.55M | -20.87M | -41.74M | -37.68M |
| Depreciation & Amortization | 69.96M | 78.26M | 82.64M | 81.98M | 81.44M | 79.73M | 80.97M | 81.03M | 83.21M | 77.64M | 98.89M | -29.48M | 29.53M |
| Stock-Based Compensation | 4.38M | 3.77M | 613K | 919K | 1.19M | 1.33M | 1.34M | 1.32M | 1.24M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 37.52M | 26.52M | 24.21M | 16.4M | 32.72M | 43.69M | 38.99M | 62.72M | 44.05M | 36.3M | 17.21M | 158.79M | 655K |
| Working Capital Changes | -15.24M | -45.62M | 558K | -6.46M | -10.18M | 57K | -8.63M | -9.36M | -21.63M | -7.43M | -16.5M | -18.89M | 2.81M |
| Cash from Investing | -13.66M | 69.81M | 63.97M | -62.82M | -41.78M | -47.92M | -82.49M | -46.25M | -115.06M | -193.94M | -19.09M | -556.33M | -1.53B |
| Acquisitions (Net) | 0 | 0 | 0 | 284K | 0 | 0 | 0 | 0 | 0 | 1.34M | 0 | 500K | 0 |
| Purchase of Investments | -1.78M | -1.38M | -5.61M | -9.96M | -25.54M | -159.3M | -94.98M | -92M | -128.06M | -188.93M | -38.75M | -570.23M | -1.53B |
| Sale of Investments | 0 | 0 | 93.19M | 4.8M | 11.75M | 130.45M | 34.38M | 62.47M | 25.9M | 757K | 27.03M | 19.28M | 513K |
| Other Investing | 16.2M | 99.91M | -1.71M | -9.96M | -13.79M | -28.85M | -60.6M | -29.53M | -102.15M | 1.18M | 100K | 1M | 0 |
| Cash from Financing | -43.35M | -42.4M | -1.35M | 55.97M | 4.64M | 4.08M | 19.43M | 19.09M | 49.68M | 199.37M | -55.57M | 332.38M | 1.61B |
| Dividends Paid | -13.29M | -13.45M | -13.8M | -13.8M | -13.8M | -5.14M | -33.75M | -51.43M | -55.33M | -76.72M | -75.43M | -66.21M | -35.16M |
| Common Dividends | 0 | 0 | 0 | 0 | 0 | 0 | -31.35M | -51.43M | -55.33M | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | -2M | -1000K | 1000K | 1000K | 1000K | -1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | -535K |
| Share Repurchases | -5.42M | -5.42M | 0 | 0 | -42K | 0 | -10.54M | -21.11M | -14.2M | -33.6M | -12.18M | -10.41M | -541K |
| Other Financing | 731K | -943K | -184K | -8.65M | -1.86M | -1.62M | -3.12M | -22.02M | -3.98M | -857K | -761K | -1.33M | -5.89M |
| Net Change in Cash | -19.81M | 34.36M | -17.22M | 14.78M | -8.84M | -4.96M | -21.25M | 20.24M | -11.23M | 0 | 0 | 0 | 0 |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 108.45M | 74.09M | 91.32M | 76.54M | 85.38M | 90.35M | 111.6M | 91.36M | 102.59M | 33.19M | 29.12M | 184.4M | 0 |
| Cash at End | 106.6M | 108.45M | 74.09M | 91.32M | 76.54M | 85.38M | 90.35M | 111.6M | 91.36M | 102.59M | 33.19M | 29.12M | 184.4M |
| Free Cash Flow | 8.87M | -21.77M | -101.75M | -773K | 302K | 19.81M | 19.91M | 30.68M | 41.24M | 55.69M | 71.25M | 61.8M | -5.49M |
| FCF Growth % | 107.04% | 78.6% | -13063.52% | -355.96% | -98.48% | -0.54% | -35.1% | -25.6% | -25.94% | -21.84% | 15.3% | 1224.77% | - |
| FCF / Revenue % | 2.59% | -6.36% | -28.76% | -0.22% | 0.09% | 6.01% | 5.22% | 8.18% | 11.38% | 17.91% | 23.56% | 24.99% | -9.4% |
Dividend coverage and liquidity
According to quarterly financial data, NHPAP's AFFO has frequently failed to cover dividend payments, with multiple quarters showing negative distributable cash flow, suggesting that the current payout policy may be reliant on capital recycling or cash reserves rather than recurring operational earnings generated by the portfolio.
The inconsistency in AFFO generation, which dipped to -$16.6 million in 2025Q4, highlights a structural inability to consistently fund distributions from core operations. Investors should monitor the dividend payout ratio closely, as the frequent periods of negative AFFO indicate that the dividend is not currently supported by the company's underlying cash-generating capacity.
As reported in the company's cash flow statements, recurring capital expenditures for tenant improvements and building maintenance consistently consume a significant portion of operating cash flow, often exceeding $5 million per quarter and further compressing the net cash available for distribution to shareholders or debt reduction.
The persistent level of maintenance capex suggests that the aging portfolio requires ongoing capital reinvestment just to maintain current occupancy levels. This high capital intensity, combined with the company's negative net income, implies that NHPAP may be trapped in a cycle where property-level reinvestment is mandatory but fails to drive meaningful growth.
Based on the provided financial figures, the relationship between FFO and GAAP operating cash flow is highly erratic, with FFO/NI ratios reaching extreme levels such as 13.53 in 2025Q1, which suggests that non-cash adjustments are significantly distorting the perceived quality of the company's reported earnings.
The wide variance between GAAP operating cash flow and FFO indicates that the company's cash-based performance is heavily influenced by non-recurring items or accounting adjustments. This lack of correlation between operating cash and FFO warrants further investigation into whether the reported FFO accurately reflects the actual cash-generating potential of the medical office and senior housing assets.
Financial statements indicate that NHPAP consistently reports significant net losses, often exceeding $20 million per quarter, while FFO remains volatile, suggesting that heavy depreciation charges are masking the true extent of the operational cash burn occurring within the senior housing operating segment.
The persistent gap between GAAP net income and FFO highlights the reliance on non-cash add-backs to present a more favorable earnings picture. This discrepancy suggests that the company's profitability is fundamentally strained, and the reliance on FFO may be obscuring the reality of a business model that is struggling to achieve positive bottom-line results.
Quick answers to the most common questions about buying NHPAP stock.
National Healthcare Properties, Inc. (NHPAP) generated $7.0M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
National Healthcare Properties, Inc. (NHPAP) reported negative free cash flow of $21.8M in 2025, indicating capital requirements exceeded cash from operations.
National Healthcare Properties, Inc. (NHPAP) spent $28.7M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, National Healthcare Properties, Inc. (NHPAP) returned $13.4M to shareholders via cash dividends and spent $5.4M on share repurchases. This shows the company's commitment to returning capital to its equity investors.